BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23265704)

  • 1. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
    McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
    Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.
    Thomas RS; Sarwar N; Phoenix F; Coombes RC; Ali S
    J Mol Endocrinol; 2008 Apr; 40(4):173-84. PubMed ID: 18372406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
    Lipfert L; Fisher JE; Wei N; Scafonas A; Su Q; Yudkovitz J; Chen F; Warrier S; Birzin ET; Kim S; Chen HY; Tan Q; Schmidt A; Dininno F; Rohrer SP; Hammond ML; Rodan GA; Freedman LP; Reszka AA
    Mol Endocrinol; 2006 Mar; 20(3):516-33. PubMed ID: 16223974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.
    Held JM; Britton DJ; Scott GK; Lee EL; Schilling B; Baldwin MA; Gibson BW; Benz CC
    Mol Cancer Res; 2012 Aug; 10(8):1120-32. PubMed ID: 22669764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated ERK1/ERK2/estrogen receptor cross-talk enhances estrogen-mediated signaling during long-term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Dowsett M
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S75-84. PubMed ID: 16113101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
    J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitogen-activated protein kinase (MAPK) pathway mediates the oestrogen-like activities of ginsenoside Rg1 in human breast cancer (MCF-7) cells.
    Lau WS; Chen WF; Chan RY; Guo DA; Wong MS
    Br J Pharmacol; 2009 Apr; 156(7):1136-46. PubMed ID: 19298253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin induces, via ERK1/ERK2 signal, functional activation of estrogen receptor alpha in MCF-7 cells.
    Catalano S; Mauro L; Marsico S; Giordano C; Rizza P; Rago V; Montanaro D; Maggiolini M; Panno ML; Andó S
    J Biol Chem; 2004 May; 279(19):19908-15. PubMed ID: 14985328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.
    Tang HY; Lin HY; Zhang S; Davis FB; Davis PJ
    Endocrinology; 2004 Jul; 145(7):3265-72. PubMed ID: 15059947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin controls ERα and HER2 signaling in mammospheres of ERα-positive breast cancer cells and interferes with the efficacy of molecular targeted therapy.
    Fukui F; Hayashi SI; Yamaguchi Y
    J Steroid Biochem Mol Biol; 2020 Jul; 201():105698. PubMed ID: 32404282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium arsenite inhibited genomic estrogen signaling but induced pERα (Ser118) via MAPK pathway in breast cancer cells.
    Nakareangrit W; Thiantanawat A; Visitnonthachai D; Watcharasit P; Satayavivad J
    Environ Toxicol; 2016 Sep; 31(9):1133-46. PubMed ID: 25728338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.
    Fan P; Wang J; Santen RJ; Yue W
    Cancer Res; 2007 Feb; 67(3):1352-60. PubMed ID: 17283173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase.
    Joel PB; Traish AM; Lannigan DA
    J Biol Chem; 1998 May; 273(21):13317-23. PubMed ID: 9582378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-independent activation of oestrogen receptor alpha by caveolin-1.
    Schlegel A; Wang C; Pestell RG; Lisanti MP
    Biochem J; 2001 Oct; 359(Pt 1):203-10. PubMed ID: 11563984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-serine-118 estrogen receptor-alpha detection in human breast tumors in vivo.
    Murphy L; Cherlet T; Adeyinka A; Niu Y; Snell L; Watson P
    Clin Cancer Res; 2004 Feb; 10(4):1354-9. PubMed ID: 14977836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ERα-mediated rapid estrogenic actions of ginsenoside Rg1 and estren in human breast cancer MCF-7 cells.
    Gao QG; Chan HY; Man CW; Wong MS
    J Steroid Biochem Mol Biol; 2014 May; 141():104-12. PubMed ID: 24508513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low phosphorylation of estrogen receptor alpha (ERalpha) serine 118 and high phosphorylation of ERalpha serine 167 improve survival in ER-positive breast cancer.
    Yamashita H; Nishio M; Toyama T; Sugiura H; Kondo N; Kobayashi S; Fujii Y; Iwase H
    Endocr Relat Cancer; 2008 Sep; 15(3):755-63. PubMed ID: 18550720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells.
    Oh AS; Lorant LA; Holloway JN; Miller DL; Kern FG; El-Ashry D
    Mol Endocrinol; 2001 Aug; 15(8):1344-59. PubMed ID: 11463858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.
    Chen D; Washbrook E; Sarwar N; Bates GJ; Pace PE; Thirunuvakkarasu V; Taylor J; Epstein RJ; Fuller-Pace FV; Egly JM; Coombes RC; Ali S
    Oncogene; 2002 Jul; 21(32):4921-31. PubMed ID: 12118371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.